Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Cells and Metastasis, Mechanisms of cancer metastasis, Cancer Genomics and Diagnostics, and Protein Degradation and Inhibitors.
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
Clinical Utility of Functional Precision Medicine in the Management of Recurrent/Relapsed Childhood Rhabdomyosarcoma
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells
Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures
Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responses
Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models <i>In Vitro</i> and <i>In Vivo</i>